CNBC Television published this video item, entitled “Biogen shares spike after FDA approves Alzheimer’s drug” – below is their description.
Biogen shares spiked in Monday’s session after the FDA approved its controversial Alzheimer’s drug, which is the first new therapy for the disease in nearly two decades. CNBC’s Meg Tirrell reports.
CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.